Syndax
  • Home
  • About Us
    • Back
    • About Us
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Vision, Mission, and Values
  • Patients & Caregivers
  • Pipeline
    • Back
    • Pipeline
    • Entinostat
    • SNDX-6352-0503 Trial
    • SNDX-5613 Trial
    • Clinical Trials
    • Publications
    • Compassionate Use
  • Investors
  • Collaboration
  • Career Opportunities
  • Contact Us
Syndax
Contact Us
  • About
  • Patients & Caregivers
  • Pipeline
  • Investors
  • Collaboration
  • Join Us

Determined to realize a future in which people with cancer live longer and better than ever before.


  • What is entinostat?
  • What is axatilimab?
  • What is SNDX-5613?
  • What clinical trials is Syndax currently conducting?
  • Who is on the leadership team at Syndax?
  • Where can I see your product pipeline?
  • What is the vision of Syndax?
  • Is Syndax hiring?
  • How can my organization collaborate with Syndax?
Pipeline
Leadership
Clinical Trials
Publications

12.18.20

Syndax Pharmaceuticals To Be Added to the NASDAQ Biotechnology Index

12.11.20

Syndax Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

12.09.20

Syndax Announces Pricing of Public Offering of Common Stock

12.07.20

Syndax Announces Proposed Public Offering of Common Stock

© 2021 Syndax | Terms of Use | Privacy Policy | Site Map
  • About Us
  • Pipeline
  • Investors
  • Collaboration
  • Career Opportunities